A Dynamic Nomogram Predicting Symptomatic Pneumonia in Patients with Lung Cancer Receiving Thoracic Radiation

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2024 Feb 26

PMID 38409084

Authors

Yawen Zha

Jingjing Zhang

Xinyu Yan

Chen Yang

Lei Wen

Minying Li

Affiliations

Soon will be listed here.

Abstract

Purpose: The most common and potentially fatal side effect of thoracic radiation therapy is radiation pneumonitis (RP). Due to the lack of effective treatments, predicting radiation pneumonitis is crucial. This study aimed to develop a dynamic nomogram to accurately predict symptomatic pneumonitis (RP ≥ 2) following thoracic radiotherapy for lung cancer patients.

Methods: Data from patients with pathologically diagnosed lung cancer at the Zhongshan People's Hospital Department of Radiotherapy for Thoracic Cancer between January 2017 and June 2022 were retrospectively analyzed. Risk factors for radiation pneumonitis were identified through multivariate logistic regression analysis and utilized to construct a dynamic nomogram. The predictive performance of the nomogram was validated using a bootstrapped concordance index and calibration plots.

Results: Age, smoking index, chemotherapy, and whole lung V5/MLD were identified as significant factors contributing to the accurate prediction of symptomatic pneumonitis. A dynamic nomogram for symptomatic pneumonitis was developed using these risk factors. The area under the curve was 0.89(95% confidence interval 0.83-0.95). The nomogram demonstrated a concordance index of 0.89(95% confidence interval 0.82-0.95) and was well calibrated. Furthermore, the threshold values for high- risk and low- risk were determined to be 154 using the receiver operating curve.

Conclusions: The developed dynamic nomogram offers an accurate and convenient tool for clinical application in predicting the risk of symptomatic pneumonitis in patients with lung cancer undergoing thoracic radiation.

Citing Articles

Development of a nomogram for predicting radiation‑induced pneumonia in patients with lung cancer undergoing close‑range radiotherapy with radioactive I particles.

Ding T, Hao S, Wang Z, Zhang W, Zhang G Mol Clin Oncol. 2024; 22(1):2.

PMID: 39534881 PMC: 11552471. DOI: 10.3892/mco.2024.2797.

References

Lu X, Wang J, Zhang T, Zhou Z, Deng L, Wang X . Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer. Front Immunol. 2022; 13:918787. PMC: 9251068. DOI: 10.3389/fimmu.2022.918787. View

Vogelius I, Bentzen S . A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012; 51(8):975-83. PMC: 3557496. DOI: 10.3109/0284186X.2012.718093. View

Kong F, Hayman J, Griffith K, Kalemkerian G, Arenberg D, Lyons S . Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006; 65(4):1075-86. DOI: 10.1016/j.ijrobp.2006.01.051. View

Katsuta Y, Kadoya N, Kajikawa T, Mouri S, Kimura T, Takeda K . Radiation pneumonitis prediction model with integrating multiple dose-function features on 4DCT ventilation images. Phys Med. 2022; 105:102505. DOI: 10.1016/j.ejmp.2022.11.009. View

Yang S, Huang S, Ye X, Xiong K, Zeng B, Shi Y . Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study. BMC Pulm Med. 2022; 22(1):402. PMC: 9639320. DOI: 10.1186/s12890-022-02211-8. View

Vinod S, Hau E . Radiotherapy treatment for lung cancer: Current status and future directions. Respirology. 2020; 25 Suppl 2:61-71. DOI: 10.1111/resp.13870. View

Krafft S, Rao A, Stingo F, Briere T, Court L, Liao Z . The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis. Med Phys. 2018; 45(11):5317-5324. DOI: 10.1002/mp.13150. View

Zhao J, Yorke E, Li L, Kavanagh B, Li X, Das S . Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys. 2016; 95(5):1357-1366. PMC: 5541363. DOI: 10.1016/j.ijrobp.2016.03.024. View

Shiono S, Katahira M, Abiko M, Sato T . Smoking is a perioperative risk factor and prognostic factor for lung cancer surgery. Gen Thorac Cardiovasc Surg. 2014; 63(2):93-8. DOI: 10.1007/s11748-014-0461-3. View

10.

Wang L, Liang S, Li C, Sun X, Pang L, Meng X . A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019; 105(5):1074-1085. DOI: 10.1016/j.ijrobp.2019.08.024. View

11.

Xiao L, Yang G, Chen J, Yang Y, Meng X, Wang X . Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancer. Radiother Oncol. 2018; 129(2):242-248. DOI: 10.1016/j.radonc.2018.09.005. View

12.

Adachi T, Nakamura M, Shintani T, Mitsuyoshi T, Kakino R, Ogata T . Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy. Med Phys. 2021; 48(4):1781-1791. DOI: 10.1002/mp.14769. View

13.

Tang X, Li Y, Tian X, Zhou X, Wang Y, Huang M . Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters. Radiother Oncol. 2018; 132:197-203. DOI: 10.1016/j.radonc.2018.10.016. View

14.

Giuranno L, Ient J, De Ruysscher D, Vooijs M . Radiation-Induced Lung Injury (RILI). Front Oncol. 2019; 9:877. PMC: 6743286. DOI: 10.3389/fonc.2019.00877. View

15.

Yang W, Hsu F, Yang P . Precision radiotherapy for non-small cell lung cancer. J Biomed Sci. 2020; 27(1):82. PMC: 7374898. DOI: 10.1186/s12929-020-00676-5. View

16.

Luna J, Chao H, Diffenderfer E, Valdes G, Chinniah C, Ma G . Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning. Radiother Oncol. 2019; 133:106-112. DOI: 10.1016/j.radonc.2019.01.003. View

17.

Zhang Z, Wang Z, Yan M, Yu J, Dekker A, Zhao L . Radiomics and Dosiomics Signature From Whole Lung Predicts Radiation Pneumonitis: A Model Development Study With Prospective External Validation and Decision-curve Analysis. Int J Radiat Oncol Biol Phys. 2022; 115(3):746-758. DOI: 10.1016/j.ijrobp.2022.08.047. View

18.

Baker R, Han G, Sarangkasiri S, DeMarco M, Turke C, Stevens C . Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2012; 85(1):190-5. DOI: 10.1016/j.ijrobp.2012.03.041. View

19.

Wang S, Liao Z, Wei X, Liu H, Tucker S, Hu C . Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006; 66(5):1399-407. DOI: 10.1016/j.ijrobp.2006.07.1337. View

20.

Sheng L, Cui X, Cheng L, Chen Y, Du X . Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer. Radiat Oncol. 2019; 14(1):229. PMC: 6916068. DOI: 10.1186/s13014-019-1440-8. View